Skip to main content
. Author manuscript; available in PMC: 2016 Dec 5.
Published in final edited form as: J Clin Pharmacol. 2011 Dec 12;52(9):1306–1316. doi: 10.1177/0091270011419854

Figure 2.

Figure 2

Plasma concentration-time profiles of MK-5046 in fasted state and after ingestion of two 120-mg oral doses taken 6 hours apart in healthy (•, n = 6/group) and obese (◦, n = 5/group) male patients. Data are arithmetic means. Large plot is linear scale; inset is the same data using a log scale.